Gladstone founder wins grant for new approach to Alzheimer's drug
December 09, 2013 at 16:27 PM EST
A $2.5 million grant to Gladstone Institutes senior investigator and founder Robert Mahley could help lay a new course toward an Alzheimer's disease treatment...